DFBHW / DFB Healthcare Acquisitions Corp. Warrant - SEC-arkivering, Årsberetning, Fuldmagtserklæring

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2026 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2026 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (

EMPLOYMENT AGREEMENT

Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 5th day of November 2024, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Russell Schuster (“Executive”). W I T N E S S E T H : WHEREAS, the Company provided Executive with an offer letter dated October 31, 2024 (the “Offer Letter”), set

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 5, 2026 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 5, 2026 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Commi

ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2026 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2026 RESULTS CONSHOHOCKEN, Pa. – May 5, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter e

FH 7.10] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 o TRANSITION REPORT PUR

FH 7.10] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defi

ARS

2025 Annual Report & Proxy StatementDear AdaptHealth Shareholder, Our aspiration at AdaptHealth is to be the most trusted and reliable partner in home healthcare – the one patients depend on and physicians choose first.

AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity, Reduced Cost of Debt, and Enhanced Financial Flexibility

Exhibit 99.1 AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity, Reduced Cost of Debt, and Enhanced Financial Flexibility CONSHOHOCKEN, Pa. – April 13, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 10, 2026 Date of Report (date of earliest event reported) AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 10, 2026 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Co

CREDIT AGREEMENT dated as of April 10, 2026 ADAPTHEALTH INTERMEDIATE HOLDCO LLC, as Intermediate Holdings, ADAPTHEALTH LLC, as the Borrower, CERTAIN SUBSIDIARIES OF INTERMEDIATE HOLDINGS PARTY HERETO FROM TIME TO TIME, as Guarantors, BANK OF AMERICA,

Exhibit 10.1 EXECUTION VERSION CUSIP Numbers: Deal: 00650YAH1 Revolver: 00650YAJ7 Term Loan A: 00650YAK4 Delayed Draw Term Loan: 00650YAL2 CREDIT AGREEMENT dated as of April 10, 2026 among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, as Intermediate Holdings, ADAPTHEALTH LLC, as the Borrower, CERTAIN SUBSIDIARIES OF INTERMEDIATE HOLDINGS PARTY HERETO FROM TIME TO TIME, as Guarantors, BANK OF AMERICA, N.A.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 24, 2026 Date of Report (date of earliest event reported) AdaptHealth Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 24, 2026 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization)

The Company’s principal subsidiaries as of December 31, 2025 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company.

Exhibit 21.1 The Company’s principal subsidiaries as of December 31, 2025 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC SOUTH CAROLINA Absolute Respiratory Care, LLC RHODE ISLAND Access Medical, LLC MICHIGAN Accu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specified in

ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS AND PROVIDES 2026 FINANCIAL GUIDANCE

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS AND PROVIDES 2026 FINANCIAL GUIDANCE CONSHOHOCKEN, Pa. – February 24, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services,

ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2025 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2025 RESULTS CONSHOHOCKEN, Pa. – November 4, 2025 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 4, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 4, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (

FH 7.10] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 o TRANSITION REPORT

FH 7.10] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registra

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 AdaptHealth Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 5, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 5, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Co

ADAPTHEALTH CORP.

Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. PARTNERS WITH A MAJOR NATIONAL HEALTHCARE SYSTEM TO BECOME THE EXCLUSIVE PROVIDER OF HOME MEDICAL EQUIPMENT CONSHOHOCKEN, Pa. – August 5, 2025 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medic

Non-Employee Director Fee Deferral Policy, effective May 30, 2025.

Exhibit 10.1 AdaptHealth Corp. Non-Employee Director Fee Deferral Policy Effective as of May 30, 2025 Pursuant to its authority under Section 3(d) of the Charter of the Compensation Committee of the Board of Directors of AdaptHealth Corp. (the “Company”), the Compensation Committee has adopted this Non-Employee Director Fee Deferral Policy (this “Policy”). Unless otherwise defined herein, capitali

ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2025 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2025 RESULTS CONSHOHOCKEN, Pa. – August 5, 2025 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quar

FH 7.10] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 o TRANSITION REPORT PURS

FH 7.10] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as

ADAPTHEALTH CORP. CLOSES TRANSACTION TO DISPOSE OF CERTAIN HOME INFUSION ASSETS AND REDUCES DEBT

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. CLOSES TRANSACTION TO DISPOSE OF CERTAIN HOME INFUSION ASSETS AND REDUCES DEBT CONSHOHOCKEN, Pa. – June 30, 2025 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of regist

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2025 AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2025 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

LETTER

June 10, 2025 Jason Clemens Chief Financial Officer AdaptHealth Corp. 220 West Germantown Pike Suite 250 Plymouth Meeting , PA 19462 Re: AdaptHealth Corp. Form 10-K for the Fiscal Year Ended December 31, 2024 Filed February 25, 2025 File No. 001-38399 Dear Jason Clemens: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy

* * *

May 28, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

LETTER

May 16, 2025 Jason Clemens Chief Financial Officer AdaptHealth Corp. 220 West Germantown Pike Suite 250 Plymouth Meeting , PA 19462 Re: AdaptHealth Corp. Form 10-K for the Fiscal Year Ended December 31, 2024 Filed February 25, 2025 File No. 001-38399 Dear Jason Clemens: We have limited our review of your filing to the financial statements and related disclosures and have the following comments. Pl

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 o TRANSITION REPORT PURSUANT T

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as speci

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 6, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Commi

Amendment, dated as of February 23, 2023, to Offer of Employment, dated as of August 17, 2022, by and between AdaptHealth Corp. and Christine Archbold.

Exhibit 10.2 February 23, 2023 Re: Updated Employment Letter Dear Christie: It is my pleasure to provide documentation of your revised offer terms with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offer of employment: The key terms are as follows: 1.Position. You are being promoted to the position of Chief Accounting Officer with an effecti

ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2025 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2025 RESULTS CONSHOHOCKEN, Pa. – May 6, 2025 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter e

Offer of Employment, dated as of August 15, 2022, by and between AdaptHealth Corp. and Christine Archbold.

Exhibit 10.1 August 15, 2022 Re: Offer of Employment Dear Christie: It is my pleasure to extend an offer of employment with AdaptHealth Corp. The key terms of this employment offer are as follows: 1.Position. You are offered the position of Senior Vice President, Accounting reporting to the Chief Financial Officer with a start date of on or around October 1, 2022. As an employee of AdaptHealth, Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defi

ARS

2024 ANNUAL REPORT & PROXY STATEMENTDear Shareholder, At AdaptHealth we believe wellness thrives at home.

Subsidiaries of the Company.

Exhibit 21.1 The Company’s principal subsidiaries as of December 31, 2024 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC SOUTH CAROLINA Absolute Respiratory Care, LLC RHODE ISLAND Access Medical, LLC MICHIGAN Accu

AdaptHealth Corp. Insider Trading Policy.

Exhibit 19.1 ADAPTHEALTH CORP. INSIDER TRADING POLICY I.Introduction Ownership by the members of the Board of Directors of AdaptHealth Corp. (the “Company”), its officers and its employees (and the directors, officers and employees of any subsidiary of the Company; all of the foregoing being referred to herein from time to time as “team members”) of Company securities is encouraged, so long as suc

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 25, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specified in

ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS AND PROVIDES 2025 OUTLOOK

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS AND PROVIDES 2025 OUTLOOK PLYMOUTH MEETING, Pa. – February 25, 2025 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announ

Amendment to Transition, Separation and Release Agreement between AdaptHealth Corp. and Shaw Rietkerk, dated December 9, 2024.

Exhibit 10.1 Amendment to Transition, Separation, and Release Agreement This amendment, delivered on December 9, 2024, confirms the following understandings and agreements between AdaptHealth Corp. (the “Company”) and Shaw Rietkerk (hereinafter referred to as “you” or “your”). WHEAREAS, the parties entered a “Transition and Separation Agreement” on August 21, 2024, and have agreed to amend section

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2024 AdaptHealth Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

AHCO / AdaptHealth Corp. / Flynn James E Passive Investment

SC 13G/A 1 e664017sc13ga-adapthealth.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 4)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) Sep

AHCO / AdaptHealth Corp. / Jefferies Financial Group Inc. - SC 13G Passive Investment

SC 13G 1 ef20038552sc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule

Joint Filing Agreement

EX-99.1 2 ef20038552ex1.htm EXHIBIT 1 EXHIBIT 1 Joint Filing Agreement This will confirm the agreement by and among all the undersigned that the Schedule 13G filed on or about this date and any amendments thereto with respect to the beneficial ownership by the undersigned of ordinary shares of AdaptHealth Corp. is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1)

AHCO / AdaptHealth Corp. / VANGUARD GROUP INC Passive Investment

SC 13G/A 1 UnitedStates13GAdaptHealt.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* (Name of Issuer) AdaptHealth Corp (Title of Class of Securiti

AHCO / AdaptHealth Corp. / BlackRock, Inc. Passive Investment

SC 13G/A 1 us00653q1022110824.txt us00653q1022110824.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) AdaptHealth Corp. - (Name of Issuer) Common Stock - (Title of Class of Securities) 00653Q102 - (CUSIP Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box

ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2024 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2024 RESULTS PLYMOUTH MEETING, Pa. – November 5, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 5, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 o TRANSITION REPORT PURSUA

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as s

AHCO / AdaptHealth Corp. / VANGUARD GROUP INC Passive Investment

SC 13G 1 UnitedStates13GAdaptHealt.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* (Name of Issuer) AdaptHealth Corp (Title of Class of Securities

by and between AdaptHealth Corp. and Albert Prast (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on October 30, 2024).

Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 30th day of October 2024 (the “Effective Date”), by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Albert Prast (“Executive”). W I T N E S S E T H : WHEREAS, Executive is currently employed by the Company as its Chief Technology Officer; a

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

AHCO / AdaptHealth Corp. / BlackRock, Inc. Passive Investment

SC 13G/A 1 us00653q1022102324.txt us00653q1022102324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) AdaptHealth Corp. - (Name of Issuer) Common Stock - (Title of Class of Securities) 00653Q102 - (CUSIP Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box

ADAPTHEALTH CORP.

Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE AdaptHealth Appoints Diana Nole to Board of Directors PLYMOUTH MEETING, Pa. – October 17, 2024 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment

Form of Indemnification Agreement

Exhibit 10.1 ADAPTHEALTH CORP INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is made as of October 16, 2024, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and [·] (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement. Certain cap

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

LETTER

October 11, 2024 Suzanne Foster Chief Executive Officer and Director AdaptHealth Corp.

* * *

October 1, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

NOTICE OF EXPIRATION DATE TO THE HOLDERS OF ADAPTHEALTH CORP. PRIVATE PLACEMENT WARRANTS

Exhibit 99.1 September 24, 2024 NOTICE OF EXPIRATION DATE TO THE HOLDERS OF ADAPTHEALTH CORP. PRIVATE PLACEMENT WARRANTS NOTICE IS HEREBY GIVEN by AdaptHealth Corp., a Delaware corporation (the “Company”), pursuant the Warrant Agreement, dated as of February 15, 2018 (the “Warrant Agreement”), by and among, the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warr

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fi

LETTER

September 20, 2024 Suzanne Foster Chief Executive Officer and Director AdaptHealth Corp.

Fourth Amendment, dated as of September 13, 2024 to the Credit Agreement, dated as of January 20, 2021 among AdaptHealth LLC, the guarantors named therein, Regions Bank, as administrative agent and collateral agent and the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 16, 2024).

Exhibit 10.1 Execution Version   FOURTH AMENDMENT   dated as of September 13, 2024   to the   CREDIT AGREEMENT   dated as of January 20, 2021   among   ADAPTHEALTH INTERMEDIATE HOLDCO LLC as Intermediate Holdings,   ADAPTHEALTH LLC, as Borrower,   CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO FROM TIME TO TIME, as the Guarantors,   THE LENDERS PARTY HERETO, and   REGIONS BANK, as Administrativ

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fi

AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt

Exhibit 99.1 Contacts AdaptHealth Corp. Jason Clemens, CFA Chief Financial Officer Investor Relations ICR Westwicke [email protected] AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt September 16, 2024 8:00 AM Eastern Daylight Time PLYMOUTH MEETING, Pa.-(BUSINESS WIRE)-AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth”

Transition Agreement by and between AdaptHealth Corp. and Shaw Rietkerk, dated August 21, 2024.

Exhibit 10.2 Execution Version TRANSITION, SEPARATION AND RELEASE AGREEMENT This Transition, Separation and Release Agreement (this “Agreement”), delivered on August 15, 2024 (the “Offer Date”), confirms the following understandings and agreements between AdaptHealth Corp. (the “Company”) and Shaw Rietkerk (hereinafter referred to as “you” or “your”). WHEREAS, the parties entered into that certain

AdaptHealth Corp. Announces New Chief Operating Officer

Exhibit 99.1 Contacts AdaptHealth Corp. Jason Clemens, CFA Chief Financial Officer [email protected] AdaptHealth Corp. Announces New Chief Operating Officer August 26, 2024 7:30 AM Eastern Daylight Time PLYMOUTH MEETING, Pa.-(BUSINESS WIRE)-AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including hom

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2024 AdaptHealth Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

Employment Agreement by and between AdaptHealth Corp. and Toby Scott Barnhart, dated August 1, 2024.

  Exhibit 10.1   Execution Version EMPLOYMENT AGREEMENT   This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 1st day of August 2024, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Toby Scott Barnhart (“Executive”).   W I T N E S S E T H :   WHEREAS, the Company desires to employ Executive and to enter into this Agreement embodying the te

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 10-Q, filed with the SEC on August 6, 2024).

Exhibit 3.2 SECOND AMENDED AND RESTATED BY LAWS OF ADAPTHEALTH CORP. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s regis

ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2024 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2024 RESULTS PLYMOUTH MEETING, Pa. – August 6, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 o TRANSITION REPORT PURSUANT TO

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specif

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 6, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Co

Transition Letter Agreement, between AdaptHealth Corp. and Joshua Parnes, dated July 2, 2024 (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed with the SEC on July 3, 2024).

Exhibit 10.1 TRANSITION, SEPARATION AND RELEASE AGREEMENT This Transition, Separation and Release Agreement (this “Agreement”), delivered on June 27, 2024 (the “Offer Date”), confirms the following understandings and agreements between AdaptHealth Corp. (the “Company”), and Joshua Parnes (hereinafter referred to as “you” or “your”). WHEREAS, following discussions initiated by the Chief Executive O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024 AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

ADAPTHEALTH CORP. ANNOUNCES CHANGES TO BOARD OF DIRECTORS AND MANAGEMENT

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES CHANGES TO BOARD OF DIRECTORS AND MANAGEMENT PLYMOUTH MEETING, Pa. – July 2, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

Fourth Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K, filed with the SEC on June 21, 2024).

Exhibit 3.1 FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAPTHEALTH CORP. June 20, 2024 AdaptHealth Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “AdaptHealth Corp.” The Corporation was originally incorporated under the name “DFB HEALTHCARE ACQUISITIONS CORP.

Amended and Restated 2019 Stock Incentive Plan of the Company.

Exhibit 10.1 AdaptHealth Corp. Second Amended and Restated 2019 Stock Incentive Plan (Effective as of June 20, 2024) 1.                  Purpose. The purpose of the Plan is to assist the Company in attracting, retaining, motivating, and rewarding certain employees, officers, directors, and consultants of the Company and its Affiliates and promoting the creation of long-term value for stockholders

Calculation of Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) ADAPTHEALTH CORP.

As filed with the Securities and Exchange Commission on June 20, 2024

As filed with the Securities and Exchange Commission on June 20, 2024 Registration No.

AHCO / AdaptHealth Corp. / Everest Hill Group Inc. - FORM SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Everest Hill Group Inc. Tropic Isle Building P.O. Box 3331 Road Town, Tortola British Virgin Islands VG1110 With copies to: Travis L. Geri

Exhibit 99.2

EX-99.2 2 exhibit99-2.htm EXHIBIT 99.2 Everest Hill Group Inc. & Affiliates Schedule 13D/A Schedule A Transactions between August 17, 2023 and March 24, 2024 Reporting Persons: Everest Hill Group Inc. and all beneficial owner affiliates as reported on the Schedule 13D/A to which this Schedule A appears an exhibit. Date Buy/Sell No. of Shares Price/Share 8/17/2023 Buy 300,000 11.4999 9/15/2023 Buy

As filed with the Securities and Exchange Commission on May 16, 2024

As filed with the Securities and Exchange Commission on May 16, 2024 Registration No.

Restricted Stock Unit Grant Notice and Agreement, effective as of May 20, 2024, by and between the Registrant and Suzanne Foster.

Exhibit 99.1 RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT As an inducement for Holder to enter into employment with AdaptHealth Corp. (the “Company”), and in reliance on Nasdaq Listing Rule 5635(c), the Company hereby grants to Holder the number of Restricted Stock Units set forth below, each Restricted Stock Unit being a notional unit representing the right to receive one share of Stock (the

Calculation of Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) ADAPTHEALTH CORP.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 7, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Commi

Revised Offer of Employment, dated September 22, 2023 between AdaptHealth Corp. and Shaw Rietkerk.

Exhibit 10.2 September 22, 2023 Re: Revised Offer of Employment Dear Shaw: It is my pleasure to provide documentation for your revised employment agreement terms with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offers of employment effective 02/26/2020 and 3/8/23: The key terms are as follows: 1.Compensation. (a)Severance: In the event tha

Revised Offer of Employment, dated December 18, 2023 between AdaptHealth Corp. and Shaw Rietkerk.

Exhibit 10.3 December 18, 2023 Re: Revised Offer of Employment Dear Shaw: It is my pleasure to extend a revised offer of employment with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offer of employment. The key terms of this employment offer are as follows: 1.Compensation. a) Base Wages: Effective January 1, 2024, you will be compensated an

Revised Offer of Employment, dated April 28, 2023, between AdaptHealth Corp. and Shaw Rietkerk.

Exhibit 10.1 April 28, 2023 Re: Revised Offer of Employment Dear Shaw: It is my pleasure to provide documentation for your revised employment agreement terms with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offer of employment effective 02/26/2020: The key terms are as follows: 1.Compensation. a.Base Compensation. Effective October 2, 2021

ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2024 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2024 RESULTS PLYMOUTH MEETING, Pa. – May 7, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quart

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 o TRANSITION REPORT PURSUANT T

] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as speci

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi

ARS

2023 ANNUAL REPORT & PROXY STATEMENTDear Shareholder, AdaptHealth provides needed medical equipment and supplies to approximately 4.

Fifth Amendment to Letter Agreement between AdaptHealth Corp. and Richard Barasch, dated April 15, 2024.

Exhibit 10.2 AdaptHealth Corp. April 15, 2024 ELECTRONIC DELIVERY Richard Barasch Re: Fifth Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by certain letter agreements by and between you and the Company, dated as of August 29, 2023,

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

ADAPTHEALTH APPOINTS SUZANNE FOSTER AS CHIEF EXECUTIVE OFFICER

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH APPOINTS SUZANNE FOSTER AS CHIEF EXECUTIVE OFFICER PLYMOUTH MEETING, Pa. – April 17, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Director

Amendment to Employment Agreement between AdaptHealth Corp. and Jason Clemens, dated April 15, 2024.

Exhibit 10.3 April 15, 2024 Re: Amendment to Employment Agreement Dear Jason: Reference is made to your employment agreement with AdaptHealth Corp.(the “Company”), dated as of May 1, 2020 (the “Employment Agreement”). Capitalized terms set forth herein will have the meanings set forth in the Employment Agreement. By signing below, you confirm our mutual understanding with respect to the following

Employment Agreement by and between AdaptHealth Corp. and Suzanne Foster, dated April 10, 2024.

Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 10 day of April 2024, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Suzanne Foster (“Executive”). W I T N E S S E T H : WHEREAS, the Company desires to employ Executive and to enter into this Agreement embodying the terms of such emplo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi

Fourth Amendment to Letter Agreement between AdaptHealth Corp. and Richard Barasch, dated March 3, 2024.

Exhibit 10.1 AdaptHealth Corp. March 3, 2024 ELECTRONIC DELIVERY Richard Barasch Re: Fourth Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by certain letter agreements by and between you and the Company, dated as of August 29, 2023,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 3, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 3, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Com

Stipulation and Agreement of Settlement, dated as of February 26, 2024.

Exhibit 10.31 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA DELAWARE COUNTY EMPLOYEES RETIREMENT SYSTEM and BUCKS COUNTY EMPLOYEES’ RETIREMENT SYSTEM, Individually and on Behalf of All Others Similarly Situated, Plaintiffs, vs. ADAPTHEALTH CORP. f/k/a DFB HEALTHCARE ACQUISITIONS CORP., LUKE MCGEE, STEPHEN P. GRIGGS, JASON CLEMENS, FRANK J. MULLEN, RICHARD BARASCH, JOSHUA PARNES, AL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 27, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 27, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization)

ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES INITIAL 2024 OUTLOOK

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES INITIAL 2024 OUTLOOK PLYMOUTH MEETING, Pa. – February 27, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services

Description of Securities.

Exhibit 4.4 DESCRIPTION OF SECURITIES We are incorporated in the State of Delaware. The rights of our stockholders are generally covered by Delaware law and our third amended and restated certificate of incorporation (as amended, “Certificate of Incorporation”) and amended and restated bylaws (as amended, “Bylaws”). The terms of our Common Stock (as defined below) are therefore subject to Delaware

AdaptHealth Corp. Policy for the Recovery of Erroneously Awarded Compensation

Exhibit 97.1 ADAPTHEALTH CORP. POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION 1.Purpose. The purpose of this Policy is to describe the circumstances in which Executives will be required to repay or return Erroneously Awarded Compensation to members of the Company Group. Each Executive shall be required to sign and return to the Company the Acknowledgement Form attached hereto as Exhib

*5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

*5 '\]''''''''''''''''''''''''''''''''''''''''''''''']'3333333333333333333 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Subsidiaries of the Company.

Exhibit 21.1 The Company’s principal subsidiaries as of December 31, 2023 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC SOUTH CAROLINA Absolute Respiratory Care, LLC RHODE ISLAND Access Medical, LLC MICHIGAN Accu

AHCO / AdaptHealth Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0181-adapthealthcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: AdaptHealth Corp Title of Class of Securities: Common Stock CUSIP Number: 00653Q102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate th

AHCO / AdaptHealth Corp. / Flynn James E Passive Investment

SC 13G/A 1 e619239sc13ga-adapthealth.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) Dec

AHCO / AdaptHealth Corp. / FMR LLC Passive Investment

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.1 ADAPTHEALTH CORP COMMON STOCK Cusip #00653Q102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #00653Q102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 8,732,999 Item 6: 0 Item 7: 8,735,305 Item 8: 0 Item 9: 8,

AHCO / AdaptHealth Corp. / BlackRock Inc. Passive Investment

SC 13G/A 1 us00653q1022010824.txt us00653q1022010824.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) AdaptHealth Corp. - (Name of Issuer) Common Stock - (Title of Class of Securities) 00653Q102 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box

Third Amendment to Letter Agreement, dated December 21, 2023, by and between AdaptHealth Corp. and Richard Barasch (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 27, 2023).

Exhibit 10.1 AdaptHealth Corp. December 21, 2023 ELECTRONIC DELIVERY Richard Barasch Re: Third Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by certain letter agreements by and between you and the Company, dated as of August 29, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 21, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 21, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization)

As filed with the Securities and Exchange Commission on December 13, 2023

As filed with the Securities and Exchange Commission on December 13, 2023 Registration No.

Calculation of Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) ADAPTHEALTH CORP.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 17, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization)

AdaptHealth LLC Non-qualified Deferred Compensation Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 22, 2023).

Exhibit 10.1 AdaptHealth LLC Non-qualified Deferred Compensation Plan Effective January 1st, 2024 IMPORTANT NOTE This document has not been approved by the Department of Labor, Internal Revenue Service, or any other governmental entity. An adopting Employer must determine whether the Plan is subject to the Federal securities laws and the securities laws of the various states. An adopting Employer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 o TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as spe

ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2023 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2023 RESULTS PLYMOUTH MEETING, Pa. – November 7, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 7, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 26, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (

Second Amendment to Letter Agreement, dated October 26, 2023, by and between AdaptHealth Corp. and Richard Barasch (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on October 31, 2023).

Exhibit 10.1 ADAPTHEALTH CORP. October 26, 2023 ELECTRONIC DELIVERY Richard Barasch Re: Second Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by that certain letter agreement by and between you and the Company, dated as of August 29

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 19, 2023 Date of Report (date of earliest event reported) AdaptHealth Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 19, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (C

Amendment to Letter Agreement, dated August 29, 2023, by and between AdaptHealth Corp. and Richard Barasch (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on August 29, 2023).

Exhibit 10.1 AdaptHealth Corp. August 29, 2023 ELECTRONIC DELIVERY Richard Barasch Re: Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp., dated as of June 26, 2023 (the “Letter Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Letter Agreemen

AHCO / AdaptHealth Corp / Everest Hill Group Inc. - FORM SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Everest Hill Group Inc. Tropic Isle Building P.O. Box 3331 Road Town, Tortola British Virgin Islands VG1110 With copies

Schedule A, setting forth transactions effectuated by the reporting persons between November 11, 2022 and August 9, 2023.

Everest Hill Group Inc. & Affiliates Schedule 13D/A Schedule A Transactions between November 11, 2022 and August 9, 2023 Reporting Persons: Everest Hill Group Inc. and all beneficial owner affiliates as reported on the Schedule 13D/A to which this Schedule A appears an exhibit. Date Buy/Sell No. of Shares Price/Share 11/11/2022 Sell 23,583 $23.000 1/10/2023 Sell 200,000 $20.384 1/12/2023 Sell 340,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 16, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 16, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (C

AHCO / AdaptHealth Corp / Peloton Equity AeroCare SPV I, L.P. - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Theodore B. Lundberg Peloton Equity, LLC 66 Field Point Road, 2nd Floor Greenwich, CT 06830 (203) 532-8011 (Name, Address and

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 o TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specifie

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Co

ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2023 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2023 RESULTS PLYMOUTH MEETING, Pa. – August 8, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second

Employment Agreement, dated July 24, 2023, by and between AdaptHealth Corp. and Albert Prast (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 27, 2023).

Exhibit 10.1 Execution Copy EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 24th day of July, 2023, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Albert Prast (“Executive”). W I T N E S S E T H : WHEREAS, Executive is currently employed by the Company as its Chief Technology Officer; and WHEREAS, Executive is a p

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2023 AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

Employment Agreement between AdaptHealth Corp. and Crispin Teufel, dated June 22, 2023.

Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 22nd day of June 2023, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Crispin Teufel (“Executive”). W I T N E S S E T H : WHEREAS, the Company desires to employ Executive and to enter into this Agreement embodying the terms of such empl

Letter Agreement, dated June 26, 2023, by and between AdaptHealth Corp. and Richard Barasch (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on June 27, 2023).

Exhibit 10.2 ADAPTHEALTH CORP. June 26, 2023 ELECTRONIC DELIVERY Richard Barasch Re:         Terms of Employment (Interim Chief Executive Officer) Dear Richard, On behalf of the Board of Directors (the “Board”) of AdaptHealth Corp. (the “Company”), I am pleased to present you with this letter (this “Letter”) setting forth the terms and conditions of your appointment as the Company’s Interim Chief

- 2 -

Exhibit 99.1 AdaptHealth Appoints Crispin Teufel as New Chief Executive Officer PLYMOUTH MEETING, Pa. – June 27, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that its Board of Directors has named Crispin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2023 AdaptHealth Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

AHCO / AdaptHealth Corp / Peloton Equity AeroCare SPV I, L.P. - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Theodore B. Lundberg Peloton Equity, LLC 66 Field Point Road, 2nd Floor Greenwich, CT 06831 (203) 532-8011 (Name, Address and

ARS

2022 ANNUAL REPORT & PROXY STATEMENTDear Shareholder, AdaptHealth is a full-service nationwide provider of products and services for patients at home and in the community, empowering them to live their healthiest lives.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 AdaptHealth Corp. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 9, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 9, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Commi

ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2023 RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2023 RESULTS PLYMOUTH MEETING, Pa. – May 9, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quart

Transition Letter Agreement, between AdaptHealth Corp. and Stephen P. Griggs, dated May 8, 2023.

Exhibit 10.1 ADAPTHEALTH CORP. May 8, 2023 Stephen P. Griggs via electronic delivery Re: Transition Agreement Dear Steve, Reference is made to that certain Employment Agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of February 1, 2021 (the “Employment Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 o TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specifi

Third Amendment dated as of March 31, 2023 to the Credit Agreement, dated as of January 20, 2021, among AdaptHealth LLC, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 10-Q filed with the SEC on May 9, 2023).

Exhibit 10.1 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of March 31, 2023 (the “Third Amendment Effective Date”), to the Credit Agreement referenced below is by and among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (“Intermediate Holdings”), ADAPTHEALTH LLC, a Delaware limited liability company (the “Borro

Offer Letter, dated as of January 15, 2018, by and between the Company and Christopher J. Joyce.

QMES January 15, 2018 Christopher J. Joyce Re: QMES Offer of Employment Dear Chris: On behalf of QMES, I am pleased to confirm our offer to you the position of General Counsel, reporting directly to me. The key terms of this employment offer (contingent on successfully passing a background check) are as follows: Base Salary and Annual Performance Bonus As General Counsel, you shall be paid an annu

AdaptHealth Announces Stephen Griggs Will Step Down as CEO at the End of Second Quarter Board Has Initiated a Search for a Successor

Exhibit 99.1 AdaptHealth Announces Stephen Griggs Will Step Down as CEO at the End of Second Quarter Board Has Initiated a Search for a Successor Plymouth Meeting, PA – May 9, 2023 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 AdaptHealth Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registra

Subsidiaries of the Company.

Exhibit 21.1 The Company’s principal subsidiaries as of December 31, 2022 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC SOUTH CAROLINA Absolute Respiratory Care, LLC RHODE ISLAND Access Medical, LLC MICHIGAN Accu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 27, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 27, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization)

ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 RESULTS AND UPDATES 2023 OUTLOOK

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 RESULTS AND UPDATES 2023 OUTLOOK PLYMOUTH MEETING, Pa. – February 27, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announc

AHCO / Adapthealth Corp / Flynn James E Passive Investment

SC 13G/A 1 e618269sc13ga-adapthealth.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) Dec

AHCO / Adapthealth Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: AdaptHealth Corp. Class A Title of Class of Securities: Common Stock CUSIP Number: 00653Q102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is fi

AHCO / Adapthealth Corp / FMR LLC Passive Investment

SC 13G 1 filing.txt SCHEDULE 13G Amendment No.0 ADAPTHEALTH CORP CLASS A COMMON STOCK Cusip #00653Q102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #00653Q102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 9,472,799 Item 6: 0 Item 7: 9,474,711 Item 8: 0 Item

AHCO / Adapthealth Corp / BlackRock Inc. Passive Investment

us00653q1022012523.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) AdaptHealth Corp. - (Name of Issuer) Common Stock - (Title of Class of Securities) 00653Q102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to

ADAPTHEALTH PROVIDES Full-year 2023 Guidance AND Preliminary Commentary on Fourth Quarter 2022 REsults

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH PROVIDES Full-year 2023 Guidance AND Preliminary Commentary on Fourth Quarter 2022 REsults PLYMOUTH MEETING, Pa. – January 10, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services,

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fil

ADAPTHEALTH CORP. Announces THIRD Quarter 2022 RESULTS AND UPDATES 2022 OUTLOOK

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. Announces THIRD Quarter 2022 RESULTS AND UPDATES 2022 OUTLOOK PLYMOUTH MEETING, Pa. ? November 8, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financi

March 31, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents March 31, ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

AHCO / Adapthealth Corp / Everest Hill Group Inc. - FORM SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Everest Hill Group Inc. Tropic Isle Building P.O. Box 3331 Road Town, Tortola British Virgin Islands VG1110 With copies

Everest Hill Group Inc. & Affiliates Schedule 13D/A Schedule A Transactions between August 10, 2022 and November 2, 2022

Everest Hill Group Inc. & Affiliates Schedule 13D/A Schedule A Transactions between August 10, 2022 and November 2, 2022 Reporting Persons: Everest Hill Group Inc. and all beneficial owner affiliates as reported on the Schedule 13D/A to which this Schedule A appears an exhibit. Date Buy/Sell No. of Shares Price/Share 08/10/2022 Sell 159,000 $23.000 08/11/2022 Sell 113,139 $23.500 08/11/2022 Sell 4

LETTER

United States securities and exchange commission logo October 21, 2022 Jason Clemens Chief Financial Officer AdaptHealth Corp.

October 7, 2022

October 7, 2022 Jason Clemens Chief Financial Officer AdaptHealth Corp. 220 W. Germantown Pike, Suite 250 Plymouth Meeting, PA 19462 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Christine Torney and Vanessa Robertson Re: AdaptHealth Corp. Form 10-K for the Fiscal Year Ended Decembe

LETTER

United States securities and exchange commission logo September 27, 2022 Jason Clemens Chief Financial Officer AdaptHealth Corp.

AHCO / Adapthealth Corp / BlackRock Inc. Passive Investment

us00653q1022090722.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) AdaptHealth Corp. - (Name of Issuer) Common Stock - (Title of Class of Securities) 00653Q102 - (CUSIP Number) August 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi

March 31, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents March 31, ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

ADAPTHEALTH REPORTS SECOND Quarter 2022 Results

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH REPORTS SECOND Quarter 2022 Results PLYMOUTH MEETING, Pa. ? August 9, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

AHCO / Adapthealth Corp / SkyKnight Aero Holdings, LLC - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Matthew Ebbel SkyKnight Capital One Letterman Drive Building C, Suite 3-950 San Francisco, CA 94129 (415) 914-0788 (Name, Address and T

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934. Dated: June 16, 2022 SKYKNIGHT A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Num

Consent Agreement, dated as of May 9, 2022, among AdaptHealth LLC, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed with the SEC on May 12, 2022).

Exhibit 10.1 CONSENT AGREEMENT THIS CONSENT AGREEMENT (this ?Agreement?) dated as of May 9, 2022, related to the Credit Agreement referenced below is by and among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (?Intermediate Holdings?), ADAPTHEALTH LLC, a Delaware limited liability company (the ?Borrower?), certain Subsidiaries of the Borrower from time to time party the

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Numb

ADAPTHEALTH REPORTS FIRST Quarter 2022 Results, UPDATES 2022 guidance, AND ANNOUNCES $200 million SHARE REPURCHASE program

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH REPORTS FIRST Quarter 2022 Results, UPDATES 2022 guidance, AND ANNOUNCES $200 million SHARE REPURCHASE program PLYMOUTH MEETING, Pa. ? May 10, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and re

Employment and Non-Competition Agreement, dated as of April 21, 2014, by and between Aerocare Holdings, Inc. and Albert Prast (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q, filed with the SEC on May 10, 2022).

Exhibit 10.2 ? EMPLOYMENT AND NON-COMPETITION AGREEMENT ? THIS EMPLOYMENT AND NON-COMPETITION AGREEMENT (this ?Agreement?) is made and entered into as of the 21st day of April, 2014, by and between Aerocare Holdings, Inc., a Delaware Company (the ?Company?), and Albert Prast (the ?Executive?). RECITALS WHEREAS, the Executive desires to serve as the Chief Technology Officer of the Company and the C

une UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents une ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Employment and Non-Competition Agreement, dated as of January 1, 2013, by and between Aerocare Holdings, Inc. and Daniel C. Bunting (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q, filed with the SEC on May 10, 2022).

Exhibit 10.1 EMPLOYMENT AND NON-COMPETITION AGREEMENT THIS EMPLOYMENT AND NON-COMPETITION AGREEMENT (this ?Agreement?) is made and entered into as of the 1st day of January, 2013, by and between Aerocare Holdings, Inc., a Delaware Company (the ?Company?), and Daniel C. Bunting (the ?Executive?). RECITALS WHEREAS, the Executive desires to serve as the Vice President of Operations and Chief Operatin

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Num

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

Subsidiaries of the Company.

Exhibit 21.1 ? The Company?s principal subsidiaries as of December 31, 2021 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. ? Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC ? SOUTH CAROLINA Absolute Respiratory Care, LLC ? RHODE ISLAND Access Medical, LLC ? MIC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

ADAPTHEALTH REPORTS Fourth Quarter and Full-Year 2021 Results And UPDATES 2022 guidance

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH REPORTS Fourth Quarter and Full-Year 2021 Results And UPDATES 2022 guidance PLYMOUTH MEETING, Pa. ? February 24, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced toda

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fil

AHCO / Adapthealth Corp / Flynn James E Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.

AHCO / Adapthealth Corp / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: AdaptHealth Corp. Class A Title of Class of Securities: Common Stock CUSIP Number: 00653Q102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fil

une UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents une ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

ADAPTHEALTH ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS, RAISES FULL-YEAR 2021 GUIDANCE, AND PROVIDES FULL-YEAR 2022 GUIDANCE

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS, RAISES FULL-YEAR 2021 GUIDANCE, AND PROVIDES FULL-YEAR 2022 GUIDANCE Plymouth Meeting, PA ? November 4, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or ?the Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplie

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

ADAPTHEALTH CORP. ANNOUNCES APPOINTMENT OF GREG BELINFANTI AS DIRECTOR

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES APPOINTMENT OF GREG BELINFANTI AS DIRECTOR Plymouth Meeting, PA ? September 30, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Greg Belin

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

Indenture, dated as of August 19, 2021, by and among AdaptHealth LLC, the guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the SEC on August 20, 2021).

Execution Version Exhibit 4.1 SENIOR NOTES INDENTURE Dated as of August 19, 2021 Among ADAPTHEALTH LLC THE GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee 5.125% SENIOR NOTES DUE 2030 TABLE OF CONTENTS Page Article 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 25 Section 1.03 R

Second Amendment dated as of August 16, 2021 to the Credit Agreement, dated as of January 20, 2021, among AdaptHealth LLC, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on August 20, 2021).

Exhibit 10.1 SECOND AMENDMENT THIS SECOND AMENDMENT (this ?Amendment?) dated as of August 16, 2021, to the Credit Agreement referenced below is by and among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (?Intermediate Holdings?), AdaptHealth LLC, a Delaware limited liability company (the ?Borrower?), certain Subsidiaries of the Borrower from time to time party thereto,

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K AdaptHealth Corp. (Exact name of registrant as specified in its charter) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 16, 2021 Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

Non-GAAP financial measures

Exhibit 99.2 Excerpts from AdaptHealth LLC?s Confidential Preliminary Offering Memorandum dated August 11, 2021. Non-GAAP financial measures We refer to the terms EBITDA, Adjusted EBITDA, Adjusted EBITDA (pro forma, as adjusted) and Adjusted EBITDA less Patient Equipment Capex (pro forma, as adjusted) (each as defined in ?Summary?Summary historical and pro forma financial data?) in various places

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File

AdaptHealth Announces Proposed Offering of $550 Million Senior Notes Due 2030

Exhibit 99.1 AdaptHealth Announces Proposed Offering of $550 Million Senior Notes Due 2030 Plymouth Meeting, PA ? August 10, 2021? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its subsidiary, AdaptHealth L

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP.

Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. The following unaudited pro forma condensed combined financial information presents the unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2021 and 2020, and the year ended December 31, 2020 based upon the combined historical financial statements of AdaptHea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

As filed with the Securities and Exchange Commission on August 6, 2021

As filed with the Securities and Exchange Commission on August 6, 2021 Registration No.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS

EX-99.1 2 tm2123465d2ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS Plymouth Meeting, PA – August 5, 2021 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related servi

Amended and Restated 2019 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed with the SEC on July 29, 2021).

Exhibit 10.1 AdaptHealth Corp. Amended and Restated 2019 Stock Incentive Plan (Effective as of July 27, 2021) 1.????????????????? Purpose. ? The purpose of the Plan is to assist the Company in attracting, retaining, motivating, and rewarding certain employees, officers, directors, and consultants of the Company and its Affiliates and promoting the creation of long-term value for stockholders of th

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

Third Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K, filed with the SEC on July 29, 2021).

Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAPTHEALTH CORP. July 28, 2021 AdaptHealth Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ?AdaptHealth Corp.? The Corporation was originally incorporated under the name ?DFB HEALTHCARE ACQUISITIONS CORP.?

July 14, 2021

July 14, 2021 VIA EDGAR Office of Life Sciences United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ? Washington, D.

LETTER

United States securities and exchange commission logo July 2, 2021 Stephen Griggs Chief Executive Officer AdaptHealth Corp.

As filed with the Securities and Exchange Commission on June 28, 2021

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 28, 2021 Registration No.

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2021 (December 14, 2020) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdicti

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP.

Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. The following unaudited pro forma condensed combined financial information presents the unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2021 and the year ended December 31, 2020 based upon the combined historical financial statements of AdaptHealth Cor

AEROCARE HOLDINGS, INC. AND SUBSIDIARIES Consolidated Financial Statements Years ended December 31, 2020 and 2019 AEROCARE HOLDINGS, INC. AND SUBSIDIARIES Table of Contents Page Independent Auditors’ Report 1 Consolidated Financial Statements Consoli

Exhibit 99.1 AEROCARE HOLDINGS, INC. AND SUBSIDIARIES Consolidated Financial Statements Years ended December 31, 2020 and 2019 AEROCARE HOLDINGS, INC. AND SUBSIDIARIES Table of Contents Page Independent Auditors? Report 1 Consolidated Financial Statements Consolidated Balance Sheets 2 Consolidated Statements of Income 3 Consolidated Statements of Comprehensive Income 4 Consolidated Statements of C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ? Washington, D.

10.1 Memorandum of Understanding for Settlement

Exhibit 10.1 MEMORANDUM OF UNDERSTANDING (?MOU?) FOR SETTLEMENT BETWEEN ADAPTHEALTH CORP. AND LUKE MCGEE Dated: June 11, 2021 Parties Luke McGee (?LM?) and AdaptHealth Corp. (together with its subsidiaries, the ?Company?). Termination of Employment Reference is made to the Employment Agreement, dated March 20, 2019, by and between AdaptHealth Holdings LLC, a Delaware limited liability company, and

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) Of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu

AdaptHealth Appoints Stephen Griggs Chief Executive Officer

Exhibit 99.1 PRESS RELEASE AdaptHealth Appoints Stephen Griggs Chief Executive Officer Plymouth Meeting, PA ? June 14, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?) announced today that its Board of Directors (the ?Board?) has appointed Stephen Griggs as Chief Executive Officer of the Company, effective immediately. Mr. Griggs, who is also a member of the Board, joined A

As filed with the Securities Exchange Commission on June 4, 2021

As filed with the Securities Exchange Commission on June 4, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ADAPTHEALTH CORP. (Exact name of registrant as specified in its charter) Delaware 82-3677704 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Ide

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )* AdaptHe

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.

Quarterly Report - 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS Plymouth Meeting, PA ? May 6, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies and related services, announced today financial results for the fir

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Numb

Employment Agreement, dated August 3, 2020, by and between the Company and Shaw Rietkerk.

Exhibit 10.14 August 3, 2020 Mr. Shaw Rietkerk ? ? Re: Employment Letter Dear Shaw, On behalf of AdaptHealth LLC (the ?Company?), I am pleased to confirm this continued offer of employment to you as Chief Operating Officer of the Company on the terms and conditions set forth below. ? ? Responsibilities Your responsibilities will continue to include (i) leadership, direction and execution of the Co

Certificate of Correction to Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.4 of the Company’s Annual Report on Form 10-K/A filed with the SEC on April 30, 2021).

? Exhibit 3.4 ? CERTIFICATE OF CORRECTION OF THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAPTHEALTH CORP. ? AdaptHealth Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?Corporation?), does hereby certify: 1. The name of the Corporation is AdaptHealth Corp. 2. The Second Amended and Restated Certificat

Subsidiaries of the Company.

Exhibit 21.1 ? The Company?s principal subsidiaries as of December 31, 2020 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. ? Subsidiaries (Alphabetically) State of Inc. ActivStyle Holding Company ? DELAWARE ActivStyle, LLC ? MINNESOTA AdaptHealth Missouri LLC ? MISSOURI Ada

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

Annual Report - 10-K/A

Table of Contents ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

First Incremental Facility Amendment dated as of April 23, 2021 to the Credit Agreement, dated as of January 20, 2021, among AdaptHealth LLC, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on April 29, 2021).

Exhibit 10.1 FIRST INCREMENTAL FACILITY AMENDMENT dated as of April 23, 2021 to the CREDIT AGREEMENT dated as of January 20, 2021 among ADAPTHEALTH INTERMEDIATE HOLDCO LLC as Intermediate Holdings, ADAPTHEALTH LLC, as Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO FROM TIME TO TIME, as the Guarantors, THE LENDERS PARTY HERETO, and REGIONS BANK, as Administrative Agent and Collateral A

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) Of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N

AdaptHealth Corp.’s Board of Directors’ Statement on Co-Chief Executive Officer Luke McGee

Exhibit 99.1 AdaptHealth Corp.?s Board of Directors? Statement on Co-Chief Executive Officer Luke McGee Plymouth Meeting, PA ? April 13, 2021 ? The Board of Directors of AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?) today issued the following statement: AdaptHealth Corp. has learned that authorities in Denmark have formally charged Co-Chief Executive Officer Luke McGee with all

Annual Report - 10-K

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Subsidiaries of the Company.

Exhibit 21.1 ? The Company?s principal subsidiaries as of December 31, 2020 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. ? Subsidiaries (Alphabetically) State of Inc. ActivStyle Holding Company ? DELAWARE ActivStyle, LLC ? MINNESOTA AdaptHealth Missouri LLC ? MISSOURI Ada

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. __)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) (

SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Theodore B. Lundberg Peloton Equity, LLC 10 Glenville Street Greenwich, CT 06831 (203) 532-8011 (Name, Address and Teleph

Joint Filing Agreement (filed herewith).

EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934. Dated: March 15, 2021 PE

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. __)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) (

SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Matthew Ebbel SkyKnight Capital One Letterman Drive Building C, Suite 3-950 San Francisco, CA 94129 (415) 914-0788 (Name,

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934. Dated: March 15, 2021 SKYKNIGHT